© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Payal Kohli, MD
Articles
After Metformin: Which Class Would you Choose?
July 10, 2019
In this older patient with T2DM, HFpEF, and other comorbidities, which class of medication is most appropriate--and guideline-recommended?
The "Sweet Spot" in Type 2 Diabetes Management
July 01, 2019
The new "sweet spot" in diabetes management is the interdisciplinary approach that is essential to treating all aspects of the disease. New diabetes medications also hit that spot.
Afib 2019 Guidelines Update: 5 Questions for Primary Care
April 03, 2019
Evidence-based revisions to the AHA/ACC/HRS guidelines will affect management of your patients with atrial fibrillation. Do you know how? Find out with a quick quiz.
New Afib Scoring System: Is it New or Just Different?
October 03, 2018
The popular CHA2DS2-Vasc stroke risk calculator has its detractors. But will a newly proposed scoring system have a significant clinical impact?
Ablation Complications: Proceed with Caution
September 06, 2018
Right atrial ablation for atrial flutter is associated with a surprisingly high rate of serious, sometimes fatal, complications. News from ESC 2018.
ARRIVE, ASCEND and the Future of Aspirin
September 06, 2018
The future role of aspirin in primary prevention of cardiovascular disease is unclear, and not for lack of scrutiny at ESC 2018.
Case in Point: Would You Anticoagulate this Patient?
August 14, 2018
The patient is an elderly man with ESRD on dialysis who goes into atrial fibrillation during fistula declotting. How to proceed?
Another Reason to Consider NOACs
July 09, 2018
A new study clears up a lingering question about the novel oral anticoagulants, VKAs, and risk of MI.
Anticoagulation Challenge: The Post-PCI Patient
March 18, 2018
A 76-year-old woman with drug eluting stent placed post-STEMI will need an antiplatelet regimen. What would you recommend?
Prophylactic LAA Closure for Stroke Prevention in AF: Is it Really As Good An Idea As We Thought?
February 13, 2018
Results of the largest study to assess impact of left atrial appendage closure during routine non-AF-related cardiac surgery raise a few new questions.